Methylphenidate

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

(2012) Caroline Moreau et al.   LANCET NEUROLOGY

Serotonin reuptake inhibitors for depression in PD

(2012) Santiago Perez-Lloret et al.   Nature Reviews Neurology

Scales to detect depression in Parkinson disease

(2012) Anette Schrag et al.   Nature Reviews Neurology

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

(2012) I. H. Richard et al.   NEUROLOGY

A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance?

(2012) Nicola Savill et al.   Child and Adolescent Psychiatry and Mental Health

Impulse control disorders in parkinson disease: A multicenter case-control study

(2011) Valerie Voon et al.   ANNALS OF NEUROLOGY

Freezing of gait: moving forward on a mysterious clinical phenomenon

(2011) John G Nutt et al.   LANCET NEUROLOGY

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

(2011) Klaus Seppi et al.   MOVEMENT DISORDERS

Methylphenidate for gait impairment in Parkinson disease: A randomized clinical trial

(2011) A. J. Espay et al.   NEUROLOGY

The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies

(2011) Lise Aagaard et al.   Neuropsychiatric Disease and Treatment

Gait-related cerebral alterations in patients with Parkinson’s disease with freezing of gait

(2010) Anke H. Snijders et al.   BRAIN

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

(2010) S. Thobois et al.   BRAIN

Medical treatment of freezing of gait

(2010) Nir Giladi   MOVEMENT DISORDERS

Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease

(2010) Jeroen Hoogland et al.   MOVEMENT DISORDERS

Apathy and Depression in Parkinson Disease

(2009) Miyako Oguru et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

(2009) K Ray Chaudhuri et al.   LANCET NEUROLOGY

Apathy may herald cognitive decline and dementia in Parkinson's disease

(2009) Kathy Dujardin et al.   MOVEMENT DISORDERS

The scientific and clinical basis for the treatment of Parkinson disease (2009)

(2009) C. W. Olanow et al.   NEUROLOGY

The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety

(2009) D.J. Heal et al.   NEUROPHARMACOLOGY

Role of dopamine receptor agonists in the treatment of early Parkinson's disease

(2009) Ubaldo Bonuccelli et al.   PARKINSONISM & RELATED DISORDERS

Methylphenidate for the Treatment of Parkinson Disease and Other Neurological Disorders

(2008) Eitan Auriel et al.   CLINICAL NEUROPHARMACOLOGY

Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease

(2008) A H Evans et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Levodopa-related motor complications-Phenomenology

(2008) Susan H. Fox et al.   MOVEMENT DISORDERS

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study

(2008) David Devos et al.   MOVEMENT DISORDERS

Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

(2008) Jaime Kulisevsky et al.   MOVEMENT DISORDERS

Levodopa unresponsive symptoms in Parkinson disease

(2008) Kapil Sethi   MOVEMENT DISORDERS

Current status of symptomatic medical therapy in Parkinson’s disease

(2008) Stewart A. Factor   Neurotherapeutics